Nature in Harmony: Music and Nature-based Self-care for Individuals With Acquired Brain Injuries and Their Care Partners
28 avril 2026 mis à jour par: Duquesne University
The goal of this pilot study is to determine the initial impact on wellbeing for clients with acquired brain injury and their care partner after engaging in a nature & music-based program facilitated by occupational therapy and music therapy. The main questions it aims to answer are:
- Primary Question: What is the impact on wellbeing for clients with acquired brain injury and their care partner after engaging in a nature & music-based program facilitated by occupational therapy and music therapy?
Secondary Question: What is the feasibility of a four-session nature & music-based wellness program for clients with acquired brain injury and care partner dyads?
- Attendance
- Satisfaction
- Accessibility
- Carryover of Strategies
Participants will complete self-reported surveys before and after completing 4 sessions of a nature & music-based program facilitated by occupational therapy and music therapy.
Aperçu de l'étude
Statut
Inscription sur invitation
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Estimé)
10
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, États-Unis, 15228
- Duquesne University
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- All participants must be above the age of 18 to participate.
- Able to communicate in English
- A person with an ABI can include persons with a diagnosis of traumatic brain injury, stroke, aneurysm, brain infection, and/or brain cancer.
- A care partner is broadly defined as a social support person who has been identified as a family member or friend of the person with the acquired brain injury.
- Capacity for consent - Person must be their own medical power of attorney
- Capacity for Self-Reflection (have a score of 23/35 on the MOCA or have a 5/6 on the Design Memory Test sub test of Cognition and Language Quick Test)
Exclusion Criteria:
- Self-reported severe-to profound hearing loss with the use of hearing aid(s)
- Cannot communicate in English
- Have a diagnosis of a progressive neurological disorder, such as Amyotrophic lateral sclerosis, Parkinson's disease, Dementia, Multiple Sclerosis
- Have a severe aphasia
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Nature In Harmony
The Nature in Harmony program involves four in-person sessions held at Duquesne University's campus using the outdoor pavilion and community garden with the final session occurring at Frick Park at their Environmental Center located in Pittsburgh, PA, between May and June of 2026.
Each session will have a minimum of two principal investigators to lead the activities.
Graduate assistants will be at each session to provide additional hands-on support for safety, mobility, and participant engagement.
Participants will be instructed to complete carryover activities between sessions: one to be completed together dyadically (person with ABI & care partner) and one to be completed individually.
Dyads will reflect on the experience in their activity journal and share and the beginning of sessions 2-4.
|
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
EUROHIS-QOL 8-item index
Délai: First session to end of program approximately 4 weeks.
|
EUROHIS-QOL 8 is a standardized assessment of general quality of life that assesses four domains of QOL: physical, psychological, social, and environmental.
This assessment has been validated for persons with traumatic brain injury (Balalla et al., 2019).
This is 5-point scale from "not at all" to "completely."
A high total point value indicates a better quality of life rating.
|
First session to end of program approximately 4 weeks.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The Connor-Davidson Resilience Scale
Délai: First session to end of program approximately 4 weeks.
|
The 10-item Connor-Davidson Resilience Scale will be administered as a secondary outcome to determine if any impacts are seen after this brief program because of participation.
This measure has been used with persons post-traumatic brain injury, stroke, and caregivers.
Rating scale goes from 0-4 with higher total scores indicating better resilence.
|
First session to end of program approximately 4 weeks.
|
|
Dyadic Relationship Scale
Délai: First day to end of program approximately 4 weeks
|
The 10-item Dyadic Relationship Scale will be administered as a secondary outcome to examine any changes in both positive and negative interactions between individuals with ABI and their care partners after this program (Sebern & Whitlatch, 2007).
This is a four point scale with a higher score indicating more negative dyad experiences.
|
First day to end of program approximately 4 weeks
|
|
Client Satisfaction Questionnaire (CSQ-8)
Délai: Last session, approximately 4 weeks after first session
|
This measure uses eight questions on a four point Likert-scale strongly agree to strongly disagree to assess participants' overall satisfaction with the program with a maximum score of 32 (Attkisson & Greenfield, 2004).
The average score for the group on the CSQ-8 is at least 24.
|
Last session, approximately 4 weeks after first session
|
|
Attendance
Délai: Every week for 4 weeks.
|
Session attendance will be tracked at every session throughout the program as either present "1" or absent "0".
Participants who attend all sessions will have a total of 4.
|
Every week for 4 weeks.
|
|
Accessibility of the strategies
Délai: Every week of the program for four weeks.
|
4-point Likert scale survey will be used to document participants' interest in using the covered strategies in the sessions.
Items will not be totaled and scales vary by question.
|
Every week of the program for four weeks.
|
|
Carryover of the strategies
Délai: Weekly journal entries for weeks 2,3, and 4.
|
A self-reported journal includes date, the name of the activity, length, and personnels will be provided for documenting the carryover activities outside of the session time.
|
Weekly journal entries for weeks 2,3, and 4.
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
4 mars 2026
Achèvement primaire (Estimé)
21 mai 2026
Achèvement de l'étude (Estimé)
1 juin 2026
Dates d'inscription aux études
Première soumission
21 avril 2026
Première soumission répondant aux critères de contrôle qualité
28 avril 2026
Première publication (Réel)
5 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
5 mai 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
28 avril 2026
Dernière vérification
1 avril 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2025/11/22
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Description du régime IPD
This was not included in the original IRB due to the small and local nature of the sample.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .